Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. - Wikidata - wikimedia - TriplyDB

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

http://www.wikidata.org/entity/Q37085001

about

Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.Effect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcoma Non-AIDS-Defining Malignancies in the HIV-Infected Population Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort Viral profiling identifies multiple subtypes of Kaposi's sarcoma.Total daily pill burden in HIV-infected patients in the southern United States.Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status Prevalence and mortality of cancer among HIV-infected inpatients in Beijing, China Disseminated Kaposi sarcoma with osseous metastases in an HIV-positive patient.Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcoma Cancer risk among the HIV-infected elderly in the United States.The role of viral co-infection in HIV-associated non-AIDS-related cancers T cell susceptibility to HIV influences outcome of opportunistic infections.Moving forward in HIV-associated cancer.Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study.Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.HIV-Associated Lung Cancer.Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?Combination antiretroviral therapy and cancer risk.HIV and Stem Cell Transplantation.Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial A man with oral lesions, constipation and back pain.Incidence of Kaposi's sarcoma and associated mortality in Fresno, California, 1998 to 2012.High Baseline Anal HPV and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent HPV Vaccine in HIV-infected individuals over 26 years old: ACTG 5298.Role of Pattern Recognition Receptors in KSHV Infection.

P2860

Q27014077-0F4E200B-F88A-49F5-87B5-30E6DE721334 Q30749748-7946331A-AC17-4753-9EE6-6B8EE01FCA29 Q33593774-AB0F1144-A808-4525-99F5-D4A19532F4BD Q33767818-A95598AE-DEDD-49D6-A28A-8DFA0E957C79 Q33814547-155E139A-30A7-40E5-AF7E-5A50B4752417 Q33859370-6284D4E7-5CA7-4BA6-B17D-C1B05D09A4EA Q33917964-402207DF-00DA-4FBF-A1F8-110B4D9CF283 Q34237734-AD1F3FB2-9E5D-45A7-87A7-F755771082E9 Q34269272-F65465C7-C296-4FF9-99E0-205E6FCD2AB2 Q34508985-0EE7E6AC-7E24-45A4-9973-12B28C231692 Q35071910-B8E5C1CD-34C1-4AB8-9285-AC748F6C205B Q35150425-DC56650A-0601-4844-A34D-83BFB01EA650 Q35589818-CE03D086-D557-45CC-A5AD-F1CA6F97852F Q35787542-D900594C-2B2F-483D-AFF8-0CEBDD331058 Q35925376-C2ADB357-E79B-4F95-B333-1FF62CD7644F Q36368521-6FD85394-4161-4F0E-A179-16FD427BD9FC Q36557592-ED57E075-56EE-4427-A517-B33A642C84FB Q36957697-3C96E039-5D64-43A2-9B9E-1EC6DAC8F438 Q36960884-43DD4C7D-6AA6-4C94-B0B5-32EC05D97B48 Q37382387-667D4DD0-6AF0-4AF6-BA14-D52C82932FB9 Q37627688-AE9973C7-FF7F-4649-85D4-9E8EFC6FD97F Q38404819-4F3955E6-ED6B-47B4-80ED-739AC914C633 Q38771101-D68F8A5C-FCBE-4159-870D-FBBEA687EDE1 Q38876754-DC356F37-FE87-472B-87E0-10E3ABF10A81 Q38929261-9A054836-D360-4BEA-9BFF-97BB90325C23 Q38963668-9B80230E-DD15-4120-9250-AF20CE11746E Q38984209-D7C9E63E-4DC5-4C4F-9193-B1FCF5064975 Q39145369-03E64976-62E0-4210-AEBA-8D1E6FFB36AD Q39437292-9889463F-A3B9-462B-A497-3F8907E4BA03 Q40702849-6E38AD25-48B1-4EB8-AC38-4441E02D569B Q42236273-35C9CCF2-3231-4D02-905D-BCAD8A86D4BF Q45988560-0A9A92E2-0E64-45EA-B7A3-8A74545FFB91 Q49711193-C64B7C46-4E4C-48F3-8343-22B9103C7452 Q55338587-C9CD92D6-861B-4731-B9D9-D5BB0B008D33

P2860

Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.

http://www.wikidata.org/entity/Q37085001

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Incidence and timing of cancer ...... nation antiretroviral therapy.

@en

Incidence and timing of cancer ...... nation antiretroviral therapy.

@nl

type

label

Incidence and timing of cancer ...... nation antiretroviral therapy.

@en

Incidence and timing of cancer ...... nation antiretroviral therapy.

@nl

prefLabel

Incidence and timing of cancer ...... nation antiretroviral therapy.

@en

Incidence and timing of cancer ...... nation antiretroviral therapy.

@nl

P1433

Q37085001-2CCB27E8-68D7-4770-86A9-1B8E492D6319

P1476

Q37085001-58D8AF03-3E86-4C8A-8801-08C347F8CBE7

P2093

Q37085001-18E18083-4A9E-4104-931D-A21877EAE0BF

Q37085001-1C91C09E-C9AE-457F-886C-FD7AB6E3A599

Q37085001-2B9BAFB2-B01A-4C59-95AD-DB0245B1AEFF

Q37085001-4B2CE28D-7ECF-4EDD-9A56-7C8555FFB363

Q37085001-63527635-C549-4526-9085-8808DA91FAF7

Q37085001-6F87B619-4B2F-4111-932B-8FB745098EA1

Q37085001-C852A4AC-28BD-4319-852C-5220B8346916

Q37085001-D33ADDD8-B77B-40AF-8F39-D7C863AE605C

Q37085001-DE47E5C0-2A4F-427B-8A69-9456091F9B85

Q37085001-E1F54E29-0B35-40FE-8A64-B00BDA8AE314

P2860

Q37085001-141B5448-71EB-4888-98E9-20010760E36D

Q37085001-153373F8-18D1-444A-A9A2-24122F49EF39

Q37085001-1FD9B397-CBB3-4345-B336-58E0AF381ADA

Q37085001-25761B9D-BA4A-42B3-B641-12188C7C6A8C

Q37085001-265A0CB9-B58D-4851-9A85-6A58B4815FB5

Q37085001-2803A2FF-A6D0-4BCC-8D19-7D374A493E4D

Q37085001-2D9529C8-5A6D-45D3-85B8-94FD17477005

Q37085001-2E735F6D-718B-4DDC-A35F-80006E75FDF0

Q37085001-417C2F87-E826-4D29-8FF0-6954798BD4BF

Q37085001-45438F0C-49C4-4B28-B516-F222DE1C6AB7

P304

Q37085001-AA4CCE75-E1CB-4B5D-8E0B-D94548B2E891

P31

Q37085001-409F79EB-D58D-4959-A781-71F936822BDA

P356

Q37085001-2579B7CE-D2CF-48B2-BD0F-3F8D042F19A4

P407

Q37085001-B0D4DAC9-40A5-469A-8DDD-8F835A25A9E6

P433

Q37085001-61BCF546-038F-4EB2-A820-CE7697897815

P478

Q37085001-D1A6D577-CA3E-45CA-829D-5AABE55F2106

P50

Q37085001-4071D65A-AA7E-4EE3-B324-2A28C9197E7C

Q37085001-797AEC27-D434-4CC4-88AC-226B73EBBEB9

Q37085001-C89B77CB-0FD0-47FB-80D2-7BAFD860C874

Q37085001-D49DB28D-F2C1-486B-AE4D-C11AB17CD3C0

Q37085001-E6BDDA5F-EEF5-48BB-9A07-FDFA945906D6

P577

Q37085001-226D2991-5775-4658-823A-6AF31D7E9AFA

P5875

Q37085001-435CA474-F8D5-444E-A940-0B4A4420D649

P698

Q37085001-7EC94457-8D62-49D6-9CAB-C4E22EDD4221

P921

Q37085001-1AD5189E-3B04-46CC-B606-4BA1070DCADF

Q37085001-EEBF6D16-6134-47C7-8750-6FF1AA33FC4D

P932

Q37085001-6CBBE9CF-5AEE-437D-B780-DB3B8AB43AED

P356

P1433

Clinical Infectious Diseases

P1476

Incidence and timing of cancer ...... nation antiretroviral therapy.

@en

P2093

Andrew Olshan

http://www.w3.org/2001/XMLSchema#string

Dirk P Dittmer

http://www.w3.org/2001/XMLSchema#string

Kenneth Mayer

http://www.w3.org/2001/XMLSchema#string

Mari M Kitahata

http://www.w3.org/2001/XMLSchema#string

Michael J Mugavero

http://www.w3.org/2001/XMLSchema#string

Michael Saag

http://www.w3.org/2001/XMLSchema#string

Peter W Hunt

http://www.w3.org/2001/XMLSchema#string

Richard D Moore

http://www.w3.org/2001/XMLSchema#string

Satish Gopal

http://www.w3.org/2001/XMLSchema#string

Stephen R Cole

http://www.w3.org/2001/XMLSchema#string

P2860

Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.

Cancer as a cause of death among people with AIDS in the United States.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.

Trends in cancer risk among people with AIDS in the United States 1980-2002.

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.

Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.

AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Cancer burden in the HIV-infected population in the United States

P304

756-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIT369

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth L. Yanik

Benigno Rodriguez

Sonia Napravnik

P577

2013-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237055499

http://www.w3.org/2001/XMLSchema#string

P698

23735330

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3739467

http://www.w3.org/2001/XMLSchema#string